▼ SELL
10b5-1 Plan
$ Value
$86K
Shares
8,552
Price
$10
Filed
Nov 10
Insider
Name
Dayal Sujata Tyagi
Title
—
CIK
0001536908
Roles
Director
Transaction Details
Transaction Date
2025-11-07
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
88,980
Footnotes
All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on August 8, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). | All shares sold at an exact price of $10.00.
Filing Info
Dayal Sujata Tyagi's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-07 | EBS | ▼ | $86K |
| 2025-04-30 | EBS | A | $0 |
| 2025-04-30 | EBS | A | $0 |
Other Insiders at EBS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FOWLER JOHN D JR | — | — | 2026-03-03 |
|
LINDAHL RICHARD S
EVP, Chief Financial Officer
|
— | — | 2026-03-05 |
|
PAPA JOSEPH C
President and CEO
|
— | — | 2026-03-05 |
|
Glessner Coleen
EVP, Quality & Ethics, and CPL
|
— | — | 2026-03-05 |
|
Williams Paul Anthony
SVP, Products Business
|
— | $34K | 2026-04-01 |
|
Hartzel William
SVP, Bioservices
|
— | — | 2026-03-05 |
|
Perl Jessica
SVP, General Counsel, Corp Sec
|
— | — | 2026-03-05 |
|
Lowry Simon C
SVP, R&D, CMO
|
— | — | 2026-03-05 |